LITTLE FALLS, N.J.,
Sept. 22, 2014
/PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN) will
release the results for its fourth quarter and fiscal 2014
ended July 31, 2014 on Monday, September 29 before the market opens, and
hold a conference call to discuss the results at 11:00 AM ET. Participating in the call will be
Charles M. Diker, Chairman;
Andrew A. Krakauer, President and
CEO; Jorgen B. Hansen, Executive
Vice President and COO; Craig A.
Sheldon, Senior Vice President, CFO and Treasurer; and
Seth Yellin, Senior Vice
President-Corporate Development.
To participate in the conference call, dial (877) 407-8033
approximately 5 to 10 minutes before the beginning of the call. If
you are unable to participate, a digital replay of the call will be
available from Monday, September 29,
2014 through midnight on November 29,
2014 by dialing (877) 660-6853 and using conference ID #
13590980.
The call will be simultaneously broadcast live over the Internet
on vcall.com at
http://www.investorcalendar.com/IC/CEPage.asp?ID=173195 . A replay
of the webcast will be available for 90 days on PrecisionIR and via
the investor relations page of the Cantel web site.
About Cantel Medical Corp.
Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention and control products and
services for patients, caregivers, and other healthcare providers
which improve outcomes, enhance safety and help save lives.
Our products include specialized medical device reprocessing
systems for endoscopy and renal dialysis, advanced water
purification equipment, sterilants, disinfectants and cleaners,
sterility assurance monitoring products for hospitals and dental
clinics, disposable infection control products primarily for dental
and GI endoscopy markets, dialysate concentrates, hollow fiber
membrane filtration and separation products, and specialty
packaging for infectious and biological specimens. Additionally, we
provide technical service for our products. For further
information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.